Ophthalmic Education:
Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist: Appendix 1: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP)
More on Ophthalmic Education:
Educational Resources:
ICO Educational Programs:
- Overview of ICO Education
- Resident and Specialist Education
- Ophthalmic Continuing Education
- ICO Continuing Education Requirements
- Medical Student Education
- Allied Ophthalmic Personnel Training
- International Congress of Ophthalmology
- ICO Basic and Clinical Assessments
- IFOS/ICO International Fellowship
- ICO International Clinical Guidelines
Recommended Reading
Blumenkranz MS, Bressler NM, Bressler SB et al. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials - TAP Report no. 5. Arch Ophthalmol 2002; 120: 1307-1314
Rubin GS, Bressler NM. Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation - TAP report No 4. Retina 2002; 22: 536-544
Bressler NM, Arnold J, Benchaboune M et al. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes - TAP report No. 3. Arch Ophthalmol 2002; 120: 1443-1454
Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 2001; 119: 198-207
Miller JW, Schmidt-Erfurth U, Sickenberg M et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 1999; 117: 1161-1173 [Erratum in: Arch Ophthalmol 2000 Apr; 118: 1488]
(No authors listed). Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 1999; 117: 1329-1345 [Erratum in: Arch Ophthalmol 2000 Apr; 118: 1488]
Next: Appendix 1: Silicone Study
Also see: Table of Contents of the Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist
You are here: Home > Ophthalmic Education > Resident and Specialist Education > Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist > Appendix 1: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP)